Navigation Links
HPV Vaccines for Cervical Cancer

Drug Pharmaceutical Company Sanofi Pasteur MSD has produced a new vaccine Gardasil which is found to prevent cervical cancer as it is found to protect infection from two strains of Human Papilloma Virus which is responsible for causing cervical cancer. //Clinical trial of the new vaccine Gardasil is being conducted by the Pharmaceutical Company.

Cervical cancer is one of the most common cancers affective the women reproductive system, which occurs mostly by the infection of Human Papilloma Virus which is transmitted sexually which transforms the normal cells on the surface of the women cervix to malignant cells.
'"/>




Page: 1

Related medicine news :

1. Producing Vaccines from genetically modified crops
2. Understanding Chronic Infections May Help in Developing Therapeutic Vaccines
3. New Anthrax Vaccines Will Take time
4. Success Of Preventable High-Risk HPV Infections With Vaccines May Vary
5. Health and Human Services stockpiles 20 million bird flu Vaccines
6. Chiron Corporation Gets US Contract To Produce Bird Flu Vaccines
7. Oral Edible vaccine for Allergy Vaccines
8. South Africa May Start Manufacturing Bird Flu Vaccines
9. Ranbaxy Laboratories All Set To Export Bird Flu Vaccines
10. From Computers to Vaccines
11. India To Produce More Cost Effective Vaccines
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: HPV Vaccines for Cervical Cancer

(Date:9/4/2008)... may be shortchanging their golden years by tappin...iversity of Illinois expert who has studied the fe..., More than three of every four Americans trim th...iming benefits early, a choice many might forego i... consequences, law professor Richard L. Kaplan say...
(Date:9/4/2008)...ncology contract research organization, has publis...uanced Approach to Get Into the Clinic Faster.&quo...al research scientist with 35 years of experience,...mmonly viewed as straightforward investigations ru...rue integration with preclinical, regulatory and c...
(Date:9/4/2008)...NORWICH, England and ONGAR, Ireland,Sept. 4 /PRNe...ofield Media,Europe Ltd, announced on the 29th Aug... publication from Silverdog Publishing., Health a... the iconic,Health and Safety at Work Act 1974 and.... It has been relied upon by blue-chip corporates,...
(Date:9/4/2008)...-FirstCall/ -- ULURU Inc. (Amex:,ULU) today announ...Weisel,Partners Healthcare Conference at 3:15 p.m....out ULURU Inc.:, ULURU Inc. is an emerging specia...ent of a portfolio of wound management, plastic su...nd consumers improved clinical,outcomes through co...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Schofield Publishing Enters the Newsletter Market 2
...alian Government has announced that it will be spe...ird flu drug Relenza from Biota Holdings. //Austra...er yesterday. The drug had been licensed by Biota...e, but Biota had alleged that GSK failed to market...
...ddenly collapsed on a family in Karawal Nagar area...e children and two adults and injuring four others...ng beside the wall of a school building, which had...eting deputy commissioner of police R.L Meena said...
... Suk the cloning pioneer of South Korea is defendi... upon the editors of Science magazine in Washingto... US scientific magazine, Donald Kennedy said that ...ertainly not ... months' to explain and support hi...
...puncture, Ayurveda, Chinese movement therapies suc...ng are just some of the commonly used alternative ... over Europe. //Perhaps, this is because it’s stro...e conventional medical treatment for cancer with t...
Other Medicine News:Health News:Scientist Calls Upon Media To Retract His Work 2
(Date:9/3/2008)...ollow up results from chronically infected Hepatit... data obtained earlier in 2008, - Study is the f...term antiviral effect of therapeutic Hepati...gly support move into a second generation, vaccin...ing through TLR acti...
(Date:9/3/2008)...Company to Discuss Phase 3 Plans with FDA, PRINCE...ics, Inc.,announced today that it successfully co... of the company,s new, innovative low-dose, once-w...rs to by its internal product,code AG-200-15. The ...t its,primary endpoint of ovulation suppression, c...
(Date:9/2/2008)...t. 3 /- Forest Laboratories...A. today announced results from,two global Phase I...ing,inhaled anticholinergic for the treatment of p... (COPD). In both the ACCLAIM/COPD I&II,(AClidinium...oderate to,Severe COPD Patients) studies, once-dai...
(Date:9/2/2008)...Meets Primary Bone Mineral Density and Secondary E...Company to Host Conference Call and Webcast Wednes...am ET / 5:30 am PT, SAN DIEGO, Sept. 2 /PRNewswir...aq: NBIX ) today announced positive safety and ef...ial using its proprietary, orally-active,nonpeptid...
Breaking Medicine Technology:Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 2Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 3Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 4Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 2Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 3Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 4Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 2Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 3Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 4Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 5Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 6Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis 2Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis 3Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis 4Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis 5Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis 6A tricky tumor virus 9695 1A tricky tumor virus 9695 2Just hours apart 2 brothers undergo robotic prostate cancer surgery 9693 1Just hours apart 2 brothers undergo robotic prostate cancer surgery 9693 2Relatives who decline organ donations face conflict and guilt 9691 1Relatives who decline organ donations face conflict and guilt 9691 2Relatives who decline organ donations face conflict and guilt 9691 3New gene test for prostate cancer at hand 9689 1New gene test for prostate cancer at hand 9689 2
.../PRNewswire-FirstCall/ --,Nuvelo, Inc. today annou... (R-Spondin1), a secreted protein currently in pre...ecific and potent,stimulator of gastrointestinal (...maged in patients with inflammatory bowel,conditio...is. The,study, entitled "R-Spondin1, A Novel Intes...
...abetes Insulin-Free, WASHINGTON, April 10, 2007 /P... adult stem cell therapy, the Journal of the,Ameri...udy in which,14 of 15 Juvenile Diabetes patients d... an adult stem cell treatment. According,to U.S. R...cant in,that it,s the first attempt at using stem ...
Other Medicine Technology:Nuvelo Announces Publication of NU206 Study Results in,Gastroenterology 2Nuvelo Announces Publication of NU206 Study Results in,Gastroenterology 3Nuvelo Announces Publication of NU206 Study Results in,Gastroenterology 4Newest Adult Stem Therapy Treats Diabetes 2
Recommended for aqueous samples of moderate viscosity and density. Proven ergonomic design reduces hand fatigue, prevents injury. Dry seal technology. No cleaning, no greasing. Volume Range (ul)
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,411-9) or contact custom
Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL.
Our variable volume Finnpipette Techpette combines form and function in a high performance pipette. Advanced pipetting technology, plus a colour-coded volume range, ensures quality, safety, comfort a
Medicine Products: